Anton Ostashko
Neurology · Mountain View
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Has dropped Medicare — you would pay privately
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Anton Ostashko’s office at (650) 492-7999 to ask if they take your plan before you enroll.
California Medical Board record
Licence A175602 · Current
Licensed to practise in California · since 2021 · expires 2027-12-31 · St. George'S University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$62,017
Pharmacies billed $62,017 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
545 generic and 73 brand-name prescriptions · $62,017 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 30 | $17,392 | $580 |
| Rivastigmine | 70 | $10,182 | $145 |
| Carbidopa-Levodopa | 76 | $1,612 | $21 |
| Quetiapine | 62 | $1,303 | $21 |
| Mirtazapine | 36 | $1,097 | $30 |
See all 13 drugs
| Myrbetriq | 30 | $17,392 | $580 |
| Rivastigmine | 70 | $10,182 | $145 |
| Carbidopa-Levodopa | 76 | $1,612 | $21 |
| Quetiapine | 62 | $1,303 | $21 |
| Mirtazapine | 36 | $1,097 | $30 |
| Entacapone | 12 | $986 | $82 |
| Carbidopa-Levodopa Er | 23 | $768 | $33 |
| Memantine | 30 | $678 | $23 |
| Donepezil | 41 | $658 | $16 |
| Modafinil | 15 | $533 | $36 |
| Gabapentin | 34 | $363 | $11 |
| Escitalopram | 12 | $300 | $25 |
| Sertraline | 11 | $28 | $3 |
Year by year
| 2024 | 618 | 92 | None | 12% | $62,017 |
| 2023 | 354 | 98 | None | 8% | $38,118 |
| 2022 | 83 | 33 | 0% (0) | None | $5,953 |
| 2021 | 87 | 18 | 0% (0) | None | $77,753 |
| 2020 | 51 | 19 | 0% (0) | 27% | $20,514 |
| 2019 | 57 | 22 | 0% (0) | None | $9,822 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Rivastigmine | 24 | $9,394 | $391 |
| Memantine | 28 | $1,447 | $52 |
| Carbidopa-Levodopa | 18 | $760 | $42 |
| Tizanidine | 66 | $731 | $11 |
| Donepezil | 31 | $702 | $23 |
| Duloxetine | 11 | $494 | $45 |
| Mirtazapine | 15 | $462 | $31 |
| Quetiapine | 15 | $416 | $28 |
| Gabapentin | 14 | $354 | $25 |
| Propranolol | 12 | $244 | $20 |
2021: 2 drugs
| Gabapentin | 18 | $413 | $23 |
| Levetiracetam | 13 | $220 | $17 |
Money from drug and device companies
$362 in 2025
| 2025 | 4 | 9 | None | $362 |
| 2024 | 3 | 5 | None | $230 |
| 2023 | 1 | 3 | None | $157 |
| 2022 | 2 | 3 | None | $78 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Eisai | Leqembi | $193 | 4 payments
|
| Lilly USA | Kisunla | $94 | 3 payments
|
| Life Molecular Imaging | Neuraceq | $43 | 1 payment
|
| Abbvie | Qulipta | $32 | 1 payment
|
See all 9 published payments
| Lilly USA | Meals · 2025-08-21 | Kisunla | $30 |
| Eisai | Meals · 2025-07-16 | Leqembi | $30 |
| Lilly USA | Meals · 2025-07-07 | Kisunla | $33 |
| Eisai | Meals · 2025-05-28 | Leqembi | $11 |
| Lilly USA | Meals · 2025-04-24 | Kisunla | $31 |
| Eisai | Meals · 2025-04-23 | Leqembi | $33 |
| Life Molecular Imaging | Meals · 2025-03-18 | Neuraceq | $43 |
| Abbvie | Meals · 2025-03-05 | Qulipta | $32 |
| Eisai | Meals · 2025-02-20 | Leqembi | $118 |
See earlier years (2024, 2023, 2022)
2024: $230
| Lilly USA | Kisunla | $134 | 2 payments
|
| Eisai | Leqembi | $56 | 2 payments
|
| Alexion Pharmaceuticals | None | $40 | 1 payment
|
2023: $157
| Biogen | Tecfidera | $157 | 3 payments
|
2022: $78
| Ucb | Briviact | $54 | 2 payments
|
| Biogen | Tysabri | $24 | 1 payment
|
Professional record
- NPI
- 1134617459
- Licence
- CA A175602California A175602: Current · expires 2027-12-31
More record details
- Sole proprietor
- No
- Taxonomy
- Neurology (2084N0400X)
- Mailing address
- 2500 Hospital Dr Ste 4b, Mountain View, CA, 94040
- NPI first listed
- 2018-04-23
- NPI last updated
- 2025-12-03
- NPI record certified
- 2025-12-03
This is when the NPI record was last certified, not a medical board exam.